lobbying_activities: 2593192

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2593192	590cbc34-6857-42cd-917d-6dced46bda70	Q1	PUBLIC CITIZEN	32362	PUBLIC CITIZEN	2021	first_quarter	PHA	Covid-19 medicine pricing and access, drug price negotiation, biologics exclusivity, NIST legislative package, Pandemic treatment access and affordability act, Pandemic emergency Manufacturing Act, Medicare and Medicaid prescription drug rebates, We PAID act, Empowering Medicare seniors to Negotiate drug Pricing act, global COVID 19 vaccine access, Stop Stalling act, drug price spike excise act, repealing direct to consumer advertisement tax, Stop Price Gouging Act, Preserving access to affordable generics, TRACK act, drug R&D cost transparency, using executive authority to increase vaccine production.	Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Securities & Exchange Commission (SEC),SENATE,White House Office		90000	0	0	2021-04-12T08:00:37.127000-04:00